Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study.
D000328:Adult; D014150:Antipsychotic Agents / Q000097:blood* / Q000627:therapeutic use*; D001569:Benzodiazepines; D003863:Depression / Q000097:blood* / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010865:Pilot Projects; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000097:blood* / Q000627:therapeutic use*; D012189:Retrospective Studies; D012559:Schizophrenia / Q000097:blood* / Q000150:complications / Q000188:drug therapy*
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine